A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Triple-negative breast cancer (TNBC) is a highly aggressive type of breast cancer, according to the American Cancer Society (ACS). The breast cancer vaccine that Cleveland Clinic is studying is the first that aims to prevent triple-negative breast cancer from developing, according to G. Thomas Budd, M.D., principal investigator of the phase 1 study at Cleveland Clinic’s Cancer Institute. A researcher conducts a breast cancer vaccine-related experiment in a lab at Cleveland Clinic. Original article source: Breast cancer vaccine update from Cleveland Clinic: ‘A new era’

Source: Fox News November 15, 2024 06:18 UTC